Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AlphaTON Capital Corp. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ATON
Nasdaq
2836
alphatoncapital.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AlphaTON Capital Corp.
H.C. Wainwright Initiates Coverage of AlphaTON Capital with $2 Share Price Target
- Feb 24th, 2026 5:56 am
Midnight Taps Blockdaemon, Shielded to Run Federated Nodes Ahead of March Mainnet
- Feb 19th, 2026 6:30 am
This Week In AI Chips - NVIDIA Partnership Signals Growth in AI Infrastructure Investment
- Feb 18th, 2026 4:38 am
New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America
- Feb 7th, 2026 10:55 am
Wall Street Discipline to Crypto M&A: AlphaTON Partner Yury Mitin, Live at Nasdaq
- Feb 5th, 2026 12:12 pm
New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America
- Jan 31st, 2026 8:00 am
AlphaTON Capital's Market Cap Drops To US$11m Leaving Insiders With Losses
- Jan 20th, 2026 3:43 am
BC-Most Active Stocks
- Jan 13th, 2026 8:30 am
Big AI IPOs in 2026; Blockchain Play with ATON: John Jannarone on Schwab TV
- Jan 8th, 2026 9:26 am
AlphaTON Capital: Capture the Best of Telegram Economics at a Steep Discount – Initiation Report
- Dec 18th, 2025 5:40 am
AlphaTON Capital Corp Issues Clarification on Anduril Industries Investment Program
- Dec 17th, 2025 4:57 pm
AlphaTON Capital Corp Announces Intention to Launch Decentralized AI-Native Biotech Platform Focused on Rare Cancers
- Dec 17th, 2025 8:07 am
AI Chips Update - AlphaTON Capital Expands AI Capabilities With NVIDIA B300 Integration
- Dec 17th, 2025 4:37 am
AlphaTON Capital Corp Announces Historic Strategic $30 Million Investment in Anduril Industries
- Dec 16th, 2025 7:00 am
Public Gateway to Telegram Economy: AlphaTON Executive Chairman Enzo Villani, Live at Nasdaq
- Dec 10th, 2025 1:42 pm
AI Chips Update - AlphaTON Invests $82.5M In Nvidia-Powered AI Expansion
- Nov 28th, 2025 4:37 am
AlphaTON Commits $82.5 Million to Telegram's Cocoon AI, Including Nvidia GPU Cluster
- Nov 26th, 2025 8:43 am
Wall Street Eyes Monetary Policy Cues, Driving Premarket Gains for US Equity Futures
- Nov 24th, 2025 7:08 am
HIT: Strong 3Q & Outlook, With New Solutions Recently Introduced, Others Being Developed
- Nov 12th, 2025 5:13 am
AlphaTON’s Cyncado Therapeutics and Australia’s ADDRI to Launch Investigator-Initiated Mesothelioma Clinical Trial of TT-4, Complementing U.S. Plans
- Nov 12th, 2025 5:00 am
Scroll